Home > Insider Trading > Filing (0001093557-24-000053)

Filing Details

Accession Number:: 0001093557-24-000053
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-03-14 17:40:37
Reporting Period:: 2024-03-12

Accepted Time:: 2024-03-14 17:40:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1797971	Sadie Stern	6340 Sequence Drive San Diego CA 92121	Evp Chief Human Resources	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2024-03-12	11,633	$134.41	89,129	No	4	S	Direct
Common Stock	Disposition	2024-03-12	2,437	$131.50	86,692	No	4	S	Direct
Common Stock	Disposition	2024-03-12	2,577	$132.46	84,115	No	4	S	Direct
Common Stock	Disposition	2024-03-12	3,297	$133.43	80,818	No	4	S	Direct
Common Stock	Disposition	2024-03-12	302	$131.51	80,516	No	4	S	Direct
Common Stock	Disposition	2024-03-12	75	$132.71	80,441	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Included in this number are 53,995 unvested restricted stock units, 21,711 of which were granted on March 8, 2024 and shall vest through March 8, 2027, 14,512 of which were granted on March 8, 2023 and shall vest through March 8, 2026, 7,060 of which were granted on March 8, 2022 and shall vest through March 8, 2025, 2,504 of which were granted on December 15, 2021 and shall vest through December 15, 2024, 8,208 of which were granted on November 19, 2020 and shall vest through November 19, 2024.
On December 15, 2022, Ms. Stern adopted a 10b5-1 Plan which was amended on December 12, 2023. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Stern. The shares set forth above were sold pursuant to the 10b5-1 Plan.
This transaction was executed in multiple trades at prices ranging from $130.89 to $131.84. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $131.98 to $132.86. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $133.00 to $133.92. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $131.36 to $131.80. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $132.62 to $133.00. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.